Literature DB >> 11585456

Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs.

H Chen1, F Noble, B P Roques, M C Fournié-Zaluski.   

Abstract

Prodrugs of phosphinic dual inhibitors of the enkephalin degrading enzymes, neutral endopeptidase (NEP) and aminopeptidase N (APN), corresponding to the formula H(3)N(+)CH(R(1))P(O)(OR)CH(2)CH(CH(2)Bip)CONHCH(CH(3))COOCH(2)Ph, with R(1) = CH(3) or Ph and R being a benzyl ester, a S-acyl-2-thioethyl derivative, or an acyloxyalkyl group, were synthesized to improve the poor central bioavailability of their precursors. As expected, these compounds (50 mg/kg, iv or ip) induced long lasting ( approximately 2 h) antinociceptive responses in the hot plate test in mice with a ceiling effect varying between 25 and 42% of analgesia. A very rapid hydrolysis of the carboxylate ester contrasting with a slow deprotection of the phosphinate group (t(1/2) approximately 1 h) was observed in serum while 80% of free drug was obtained after 1 h incubation with brain membranes. These results account for the long duration of action observed with these prodrugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585456     DOI: 10.1021/jm0102248

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Prodrug approaches for CNS delivery.

Authors:  Jarkko Rautio; Krista Laine; Mikko Gynther; Jouko Savolainen
Journal:  AAPS J       Date:  2008-02-05       Impact factor: 4.009

Review 2.  Dual Enkephalinase Inhibitors and Their Role in Chronic Pain Management.

Authors:  Warren A Southerland; Justin Gillis; Sumanth Kuppalli; Alex Fonseca; Andrew Mendelson; Storm V Horine; Nitin Bansal; Amitabh Gulati
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

3.  Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.

Authors:  Koteswara R Valasani; Gang Hu; Michael O Chaney; Shirley S Yan
Journal:  Chem Biol Drug Des       Date:  2012-11-14       Impact factor: 2.817

4.  Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.

Authors:  Daniel Kapitzke; Irina Vetter; Peter J Cabot
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

5.  Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.

Authors:  Elisabeth Bonnard; Hervé Poras; Xavier Nadal; Rafael Maldonado; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  Pharmacol Res Perspect       Date:  2015-01-30

Review 6.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

7.  Practical Synthesis of Phosphinic Dipeptides by Tandem Esterification of Aminophosphinic and Acrylic Acids under Silylating Conditions.

Authors:  Paraskevi Kokkala; Kostas Voreakos; Angelos Lelis; Konstantinos Patiniotis; Nikolaos Skoulikas; Laurent Devel; Angeliki Ziotopoulou; Eleni Kaloumenou; Dimitris Georgiadis
Journal:  Molecules       Date:  2022-02-12       Impact factor: 4.411

Review 8.  Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?

Authors:  Magdalena Mizerska-Dudka; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-06       Impact factor: 4.291

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.